For MS-DRG 457, the 2 cases found to report utilization of an aprevo TM customized interbody spinal fusion device appear to be outliers with a difference in average costs of $105,032 ($158,782 $53,750 = $105,032) and a shorter average length of stay (3.5 days versus 6.4 days) in comparison to all the cases in MS-DRG 457
This includes verifying your understanding of the document
The high prevalence, rapid progression and poor prognosis of CKD mean that it is necessary to find new methods to prevent and control CKD development (GBD 2015 Mortality and Causes of Death Collaborators, 2016
Blood (2011) 118:50509
Vital Flow offers NAD+ in multiple formats, including IV drips, injections, and take-home vials when appropriate
Your provider monitors your progress to ensure safe and effective results